CLINICAL_TRIALS
trial_result
· 2019-03-15
Clinical Trial Update: A Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast Cancer [Phase 1]
Summary
Phase 1 trial evaluating PF-03084014 in combination with docetaxel in advanced/metastatic breast cancer; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Breast Cancer Metastatic | Phase 1 | Status: TERMINATED | Results posted: 2019-03-15